000			02065 a2200529 4500
005			20250516213535.0
264		0	_c20150408
008			201504s 0 0 eng d
022			_a1868-8500
024	7		_a10.1007/s12672-014-0182-1 _2doi
040			_aNLM _beng _cNLM
100	1		_aLerario, Antonio M
245	0	0	_aThe combination of insulin-like growth factor receptor 1 (IGF1R) antibody cixutumumab and mitotane as a first-line therapy for patients with recurrent/metastatic adrenocortical carcinoma: a multi-institutional NCI-sponsored trial. _h[electronic resource]
260			_bHormones & cancer _cAug 2014
300			_a232-9 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
650	0	4	_aAdrenal Cortex Neoplasms _xdrug therapy
650	0	4	_aAdrenocortical Carcinoma _xdrug therapy
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal _xadministration & dosage
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAntineoplastic Agents, Hormonal _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMitotane _xadministration & dosage
650	0	4	_aNational Cancer Institute (U.S.)
650	0	4	_aNeoplasm Recurrence, Local _xdrug therapy
650	0	4	_aUnited States
650	0	4	_aYoung Adult
700	1		_aWorden, Francis P
700	1		_aRamm, Carole A
700	1		_aHesseltine, Elizabeth A
700	1		_aHasseltine, Elizabeth A
700	1		_aStadler, Walter M
700	1		_aElse, Tobias
700	1		_aShah, Manisha H
700	1		_aAgamah, Edem
700	1		_aRao, Krishna
700	1		_aHammer, Gary D
773	0		_tHormones & cancer _gvol. 5 _gno. 4 _gp. 232-9
856	4	0	_uhttps://doi.org/10.1007/s12672-014-0182-1 _zAvailable from publisher's website
999			_c23845605 _d23845605